Law360, New York (March 27, 2008, 12:00 AM ET) -- A patent dispute between two biotechnology companies over a type of protein that can be used to detect tumors has landed in federal court, after Human Genome Sciences appealed the U.S. Patent and Trademark Office's decision in an interference proceeding.
The pharmaceutical firm Human Genome Sciences filed the suit in U.S. District Court for the District of Maryland on Tuesday against Genentech Inc. The USPTO's Board of Patent Appeals and Interferences ruled in favor of Genentech in February,. But Human Genome Sciences says the decision was...
Human Genome Hits Genentech With Patent Suit
To view the full article, take a free trial now.
